Think Research Announces $3.5 Million Contract Expansion with a Global Pharmaceutical Company
Total contract value increases to $10 million from May 2022 TORONTO, ON – February 13, 2023 – Think Research Corporation (TSXV: THNK) (“Think” or the “Company”), a company focused on transforming healthcare through digital health software solutions, is pleased to announce that it has expanded its original $6.4 million contract announced on September 8, 2022, with a global pharmaceutical company […]
Think Research Secures Contract to Deliver Essential Data and Services Platform to New Customer
A Broad Range of Think Research Solutions Are Being Deployed to Help Solve Healthcare Access & Quality Challenges.
Think Research Announces Payment of Deferred Consideration by Issuance of Common Shares
TORONTO, ON – December 30, 2022 – Think Research Corporation (TSXV: THNK) (“Think” or the “Company”), a company focused on transforming healthcare through digital health software solutions, today announced that it has issued an aggregate of 546,388 common shares (the “Common Shares”) at the deemed price of $0.36 to the former shareholders of MDBriefCase Group Inc. (the “MDB Shareholders”). […]
Think Research Announces Grant of Equity Compensation
TORONTO, ON – December 21, 2022 – Think Research Corporation (TSXV: THNK) (“Think” or the “Company”), a company focused on transforming healthcare through integrated digital health software solutions, today announced that it has granted 246,485 restricted share units (each, an “RSU”) to a key employee of the Company pursuant to the Company’s Omnibus Equity Incentive […]
Think Research Announces Closing of $2.5 Million First Tranche of Previously Announced Equity Financing
TORONTO, ON – December 19, 2022 – Think Research Corporation (TSXV: THNK) (“Think” or the “Company”), an innovative disruptor focused on transforming healthcare through digital health software solutions, is pleased to announce that it has completed the first tranche of its previously announced non-brokered equity private placement (the “Equity Financing”), issuing a total of 6,250,000 common shares of the […]
Correction: Think Research Announces Third Quarter 2022 Financial and Operational Results Highlighted by Strong Revenue Growth and Continued Cost Synergies; Closes Subsequent Advance with Beedie Captial
Q3 revenue of $18.4 million grew 82% over the same period in 2021 99% revenue growth to $57.0 million in the first nine months of 2022 compared to the same period in 2021 Q3 Adjusted EBITDA nearing breakeven at ($0.7) million compared to ($3.4) million for the same period in the prior year TORONTO, ON – November 28, […]
Think Research Announces Date of Third Quarter 2022 Earnings Release and Conference Call Details
Earnings to be announced by the Company before the market opens on November 28, 2022 TORONTO, ON – November 25, 2022 — Think Research Corporation (TSXV:THNK)(OTC: THKKF) (“Think” or the “Company”), a company focused on transforming healthcare through digital health software solutions, today announced that it will release its financial results for the three months ended September […]
Think Research Enhances Financial Flexibility with New Capital Injection and Announces Amendments to Convertible Loan Facility with Beedie Capital
Additional $3 million to be received via second advance under $25 million convertible loan facility with Beedie Capital Infusion of $3 million of liquidity via non-brokered equity financing lead by Beedie Capital with $750,000 anchor investment at premium to market price per share Amendments to Beedie Capital’s $25 million Convertible Loan Facility reflects continued support […]
Think Research Corporation Amends Certain Terms Relating to the BioPharma Acquisition
TORONTO, ON, October 14, 2022 – Think Research Corporation (TSXV:THNK) (“Think” or the “Company”), a healthcare technology company focused on transforming healthcare through knowledge-based digital health software solutions, today announced that it has amended certain terms relating to the deferred consideration in the aggregate amount of $6,500,000 (the “Deferred Consideration”) owing pro rata to the sellers (the “Sellers”) […]
Think Research Announces Withdrawal from OTCQB
TORONTO, ON – October 7, 2022 – Think Research Corporation (TSXV: THNK) (“Think” or the “Company”), a company focused on transforming healthcare through integrated digital health software solutions, today announced that due to low trading volumes, Think has decided to withdraw its common shares from trading on the OTCQB venture market in the United States, effective […]
